This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
5. References
Banay-Schwartz, M, Gergely, A., and Lajtha, A., 1974, Independence of amino acid uptake from tissue swelling in incubated slices of brain, Brain Res. 65:265–276.
Brahma, B., Forman, R. E., Stewart, E. E., Nicholson, C., and Rice, M. E., 2000, Ascorbate inhibits edema in brain slices, J. Neurochem. 74:1263–1270.
De Deyn, P. P. and Macdonald, R. L., 1990, Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses in mouse neurons in cell culture, Ann. Neurol. 28:627–633.
De Deyn, P. P., Saxena, V. K., Abts, H., Borggreve, F., D’Hooge, R., Marescau, B., and Crols, R., 1992, Clinical and pathophysiological aspects of neurological complications in renal failure, Acta Neurol. Belg. 92:191–206.
De Deyn, P. P., Robitaille, P., Vanessi, M., Qureshi, I. A., and Marescau, B., 1995, Serum guanidine compounds in uremic pediatric patients treated with haemodialysis or continuous cycle peritoneal dialysis, Nephron 69:411–417.
De Deyn, P. P., D’Hooge, Van Bogaert, P.-P., and Marescau, B., 2001, Endogenous guanidino compounds as uremic neurotoxins, Kidney Int. 59(Supp. 78):S77–S83.
De Deyn, P. P., Vanholder, R., and D’Hooge, R., 2003, Nitric oxide in uremia: effects of several potentially toxic guanidine compounds, Kidney Int. 63(Supp. 84):S25–S28.
Del Olmo, N., Bustamante, J, Martín del Río, R., and Solís, J. M., 2000, Taurine activates GABAA but not GABAB receptors in rat hippocampal CA1 area, Brain Res. 864:298–307
D’Hooge, R., Van de Vijver, G., Van Bogaert, P.-P., Marescau, B., Vanholder, R., and De Deyn P. P., 2003, Involvement of voltage-and ligand-gated Ca2+ channels in the neuroexcitatory and synergistic effects of putative uremic toxins, Kidney Int. 63:1764–1775.
Fraser, C. L. and Arieff, A. L., 1988, Nervous system complications in uremia, Ann. Int. Med. 109:143–153.
Gullans, S. R. and Verbalis, J. G., 1993, Control of brain volume during hyperosmolar and hypoosmolar conditions, Annu. Rev. Med. 44:289–301.
Himmelfarb, J. and Hakim, R. M., 2003, Oxidative stress in uremia, Curr. Opin. Nephrol. Hyperten. 12:593–598.
Himmelfarb, J., McMonagle, E., Freedman, S., Klenzak, J., MacMenamin, E., Le, P., Pupim, L, B., Ikizler, T. A., and The Picard Group, 2004, Oxidative stress is increased in critically ill patients with acute renal failure. J. Am. Soc. Nephrol. 15:2449–2456.
Law, R. O., 1994a, Taurine efflux and the regulation of cell volume in incubated slices of rat cerebral cortex, Biochim. Biophys. Acta 1221:21–28.
Law, R. O., 1994b, Regulation of mammalian brain cell volume, J. Exp. Zool. 268:90–96
Law, R. O. 2005, Taurine protects against the neurotoxic effects of guanidine compounds, Amino Acids 29:15.
MacAllister, R. J., Rambausek, M. H., Vallence, P., Williams, D., Hoffmann, K. H., and Ritz, E, 1996, Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure, Nephrol. Dial. Transplant. 11:2449–2456.
Moe, S. M. and Sprague, S. M., 1994, Uremic encephalopathy, Clin. Nephrol. 42:251–256.
Pasantes-Morales, H., 1996, Volume regulation in brain cells: cellular and molecular mechanisms, Metab. Brain Dis. 11:187–204.
Pasantes-Morales, H. and Schousboe, A., 1997, Role of taurine in osmoregulation in brain cells, Amino Acids 12:281–292.
Prakash, M., Upadhya, S., and Prabhu, R., 2004, Protein thiol oxidation and lipid peroxidation in patients with uraemia, Scand. J. Lab. Clin. Invest. 64:599–604.
Quinn, M. R. and Haris, C. L., 1995, Taurine allosterically inhibits binding of [35S]-t-butylbicyclophosphorothionate (TBPS) in rat brain synaptic membranes, Neuropharmacology 34:1607–1613.
Saransaari, P. and Oja, S. S., 1998, Role of endogenous glutamate, aspartate, GABA, and taurine from hippocampal slices from adult and developing mice under cell-damaging conditions, Neurochem. Res. 23:563–570.
Saransaari, P. and Oja, S. S., 2000, Taurine and neural cell damage, Amino Acids 19:519–526.
Schaffer, S. W., Azuma, J., Takahashi, K., and Mozaffari, M., 2003, Why is taurine neuroprotective? Adv. Exp. Med. Biol. 526:307–321.
Shih, M. K. and Hu, M. L., 1999, UVA-induced oxidative damage to rat liver nuclei: reduction of iron ions and the relationship between lipid peroxidation and DNA damage, Mutation Res. 438:125–132.
Tanaka, A., Takahashi, Y., Mizokuchi, M., Shimda, M., and Koide, H., 1999, Plasma urinary and electrolyte concentrations of guanidine compounds in patients with chronic renal failure, Renal Failure 21:499–514.
Vanholder, R., et al., 2001, Uremic toxicity: present state of the art, Int. J. Artific. Organs 24:695–725.
Vanholder, R., et al., 2003, Review on uremic toxins: classification, concentration, and interindividual variability, Kidney Int. 63:1934–1943.
Vaziri, N. D., 2003, Oxidative stress in chronic renal failure: lessons learned on animal models, Blood Purif. 21:328–330.
Vaziri, N. D., 2004, Oxidative stress in uremia: nature, mechanisms, and potential consequences, Semin. Nephrol. 24:469–473.
Zielińska, M., Law, R. O., and Albrecht, J, 2003, Excitotoxic mechanism of cell swelling in rat cerebral cortical slices treated acutely with ammonia, Neurochem. Int. 43:299–303.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this paper
Cite this paper
Law, R.O. (2006). The Mechanisms of Taurine’s Protective Action against Acute Guanidino Neurotoxicity. In: Oja, S.S., Saransaari, P. (eds) Taurine 6. Advances in Experimental Medicine and Biology, vol 583. Springer, Boston, MA . https://doi.org/10.1007/978-0-387-33504-9_40
Download citation
DOI: https://doi.org/10.1007/978-0-387-33504-9_40
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-32356-5
Online ISBN: 978-0-387-33504-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)